Michael C. Peters

6.8k total citations · 1 hit paper
44 papers, 2.1k citations indexed

About

Michael C. Peters is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Michael C. Peters has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Immunology. Recurrent topics in Michael C. Peters's work include Asthma and respiratory diseases (19 papers), IL-33, ST2, and ILC Pathways (11 papers) and Respiratory and Cough-Related Research (6 papers). Michael C. Peters is often cited by papers focused on Asthma and respiratory diseases (19 papers), IL-33, ST2, and ILC Pathways (11 papers) and Respiratory and Cough-Related Research (6 papers). Michael C. Peters collaborates with scholars based in United States, Belgium and United Kingdom. Michael C. Peters's co-authors include John V. Fahy, Prescott G. Woodruff, Sally E. Wenzel, Shaopeng Yuan, Andrea M. Coverstone, Zesemayat K. Mekonnen, Nirav R. Bhakta, Max A. Seibold, David C. Yeomans and Mario Castro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Michael C. Peters

40 papers receiving 2.0k citations

Hit Papers

Plasma interleukin-6 concentrations, metabolic dysfunctio... 2016 2026 2019 2022 2016 100 200 300

Peers

Michael C. Peters
Elizabeth Tam United States
Eric W. Livingston United States
Rolf Meinert Germany
P. V. Zimmerman Australia
Jennie Hui Australia
Ahmet Akkaya Türkiye
Michael C. Peters
Citations per year, relative to Michael C. Peters Michael C. Peters (= 1×) peers Sandra C. Christiansen

Countries citing papers authored by Michael C. Peters

Since Specialization
Citations

This map shows the geographic impact of Michael C. Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Peters more than expected).

Fields of papers citing papers by Michael C. Peters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Peters. The network helps show where Michael C. Peters may publish in the future.

Co-authorship network of co-authors of Michael C. Peters

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Peters. A scholar is included among the top collaborators of Michael C. Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Peters. Michael C. Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuroki, Taichi, et al.. (2023). Temperature Rise on Liner Surfaces of Fuel Cell Electric Vehicle Tanks during Fueling Process. Energy Technology. 11(9). 3 indexed citations
2.
Al‐Shaikhly, Taha, Ryan C. Murphy, Ying Lai, et al.. (2022). Location of eosinophils in the airway wall is critical for specific features of airway hyperresponsiveness and T2 inflammation in asthma. European Respiratory Journal. 60(2). 2101865–2101865. 43 indexed citations
3.
Peters, Michael C., et al.. (2022). Novel potential treatable traits in asthma: Where is the research taking us?. Journal of Allergy and Clinical Immunology Global. 1(2). 27–36. 5 indexed citations
4.
Permaul, Perdita, Michael C. Peters, Carter R. Petty, et al.. (2021). The association of plasma IL-6 with measures of asthma morbidity in a moderate-severe pediatric cohort aged 6-18 years. The Journal of Allergy and Clinical Immunology In Practice. 9(7). 2916–2919.e2. 13 indexed citations
5.
Peters, Michael C., David T. Mauger, Kristie Ross, et al.. (2020). Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency. American Journal of Respiratory and Critical Care Medicine. 202(7). 973–982. 101 indexed citations
6.
Peters, Michael C. & Sally E. Wenzel. (2020). Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma. The Lancet. 395(10221). 371–383. 93 indexed citations
7.
Coverstone, Andrea M., Max A. Seibold, & Michael C. Peters. (2020). Diagnosis and Management of T2-High Asthma. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 442–450. 62 indexed citations
8.
Altman, Matthew C., Ying Lai, James D. Nolin, et al.. (2019). Airway epithelium–shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling. Journal of Clinical Investigation. 129(11). 4979–4991. 68 indexed citations
9.
Denlinger, Loren C., Brenda R. Phillips, Ronald L. Sorkness, et al.. (2019). Insensitivity to Corticosteroids Predicts Longitudinal Loss of Lung Function in the NHLBI Severe Asthma Research Program (SARP III). A2680–A2680.
10.
Li, Xingnan, Annette T. Hastie, Michael C. Peters, et al.. (2019). Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma. Journal of Allergy and Clinical Immunology. 145(1). 430–433. 48 indexed citations
11.
Peters, Michael C., Nathan Dyjack, Prescott G. Woodruff, et al.. (2018). A Transcriptomic Method to Determine Airway Immune Dysfunction in T2-High and T2-Low Asthma. American Journal of Respiratory and Critical Care Medicine. 199(4). 465–477. 105 indexed citations
12.
McGrath, Kevin, Loren C. Denlinger, Eugene R. Bleecker, et al.. (2017). Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control. CHEST Journal. 153(2). 378–386. 4 indexed citations
13.
Gordon, Erin, Laura J. Simpson, Cydney Rios, et al.. (2016). Alternative splicing of interleukin-33 and type 2 inflammation in asthma. Proceedings of the National Academy of Sciences. 113(31). 8765–8770. 117 indexed citations
14.
Peters, Michael C., Kevin McGrath, Gregory A. Hawkins, et al.. (2016). Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. The Lancet Respiratory Medicine. 4(7). 574–584. 370 indexed citations breakdown →
15.
Gordon, Erin, Joe Palandra, Agata Wesolowska‐Andersen, et al.. (2016). IL1RL1 asthma risk variants regulate airway type 2 inflammation. JCI Insight. 1(14). e87871–e87871. 43 indexed citations
16.
Peters, Michael C., et al.. (2016). Biomarkers of Airway Type-2 Inflammation and Integrating Complex Phenotypes to Endotypes in Asthma. Current Allergy and Asthma Reports. 16(10). 71–71. 12 indexed citations
17.
Peters, Michael C., Zesemayat K. Mekonnen, Shaopeng Yuan, et al.. (2013). Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. Journal of Allergy and Clinical Immunology. 133(2). 388–394.e5. 251 indexed citations
18.
Yeomans, David C., Ying Lü, Charles E. Laurito, et al.. (2005). Recombinant herpes vector-mediated analgesia in a primate model of hyperalgesia. Molecular Therapy. 13(3). 589–597. 46 indexed citations
19.
Jones, Toni L., Sarah M. Sweitzer, Michael C. Peters, Steven P. Wilson, & David C. Yeomans. (2004). GABAB receptors on central terminals of C‐afferents mediate intersegmental Aδ‐afferent evoked hypoalgesia. European Journal of Pain. 9(3). 233–233. 11 indexed citations
20.
Sweitzer, Sarah M., Michael C. Peters, Ruban Mangadu, et al.. (2004). Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia. Pain. 111(3). 278–285. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026